Patents Assigned to Chavah Pty Ltd.
  • Patent number: 9616072
    Abstract: The present invention is directed generally to pharmaceutical compositions, methods, and kits for improving side effects associated with aromatase inhibitor treatment in a subject diagnosed with breast cancer. More specifically, the present invention provides compositions, methods, and kits comprising an aromatase inhibitor and an androgenic agent.
    Type: Grant
    Filed: September 14, 2015
    Date of Patent: April 11, 2017
    Assignee: CHAVAH PTY LTD.
    Inventor: Stephen Nigel Birrell
  • Patent number: 9351977
    Abstract: The present disclosure is directed to generally methods for treating mammographic breast density and/or breast stiffness in a patient in need thereof, such as a premenopausal or perimenopausal patient, comprising the administration of an effective amount of androgenic agent and an effective amount of an aromatase inhibitor. These methods may also be useful in post-menopausal woman.
    Type: Grant
    Filed: October 22, 2015
    Date of Patent: May 31, 2016
    Assignee: CHAVAH PTY LTD.
    Inventor: Stephen Nigel Birrell
  • Patent number: 9168302
    Abstract: The present invention is directed generally to pharmaceutical compositions, methods, and kits for improving side effects associated with aromatase inhibitor treatment in a subject diagnosed with breast cancer. More specifically, the present invention provides compositions, methods, and kits comprising an aromatase inhibitor and an androgenic agent.
    Type: Grant
    Filed: January 19, 2012
    Date of Patent: October 27, 2015
    Assignee: Chavah Pty Ltd
    Inventor: Stephen N. Birrell
  • Publication number: 20120122824
    Abstract: The present invention is directed generally to pharmaceutical compositions, methods, and kits for improving side effects associated with aromatase inhibitor treatment in a subject diagnosed with breast cancer. More specifically, the present invention provides compositions, methods, and kits comprising an aromatase inhibitor and an androgenic agent.
    Type: Application
    Filed: January 19, 2012
    Publication date: May 17, 2012
    Applicant: Chavah Pty Ltd
    Inventor: Stephen N. Birrell
  • Publication number: 20090215731
    Abstract: The present invention is directed generally to pharmaceutical compositions, methods, and kits for improving side effects associated with aromatase inhibitor treatment in a subject diagnosed with breast cancer. More specifically, the present invention provides compositions, methods, and kits comprising an aromatase inhibitor and an androgenic agent.
    Type: Application
    Filed: October 18, 2006
    Publication date: August 27, 2009
    Applicant: Chavah Pty Ltd.
    Inventor: Stephen Nigel Birrell